BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pathology News - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pathology News
X-ORIGINAL-URL:https://www.pathologynews.com
X-WR-CALDESC:Events for Pathology News
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251017
DTEND;VALUE=DATE:20251022
DTSTAMP:20260830T154859
CREATED:20250710T100115Z
LAST-MODIFIED:20250731T142312Z
UID:100114263-1760659200-1761091199@www.pathologynews.com
SUMMARY:ESMO Congress 2025
DESCRIPTION:0000Days00Hrs00Min00SecThe ESMO Congress is a highly influential global oncology platform for clinicians\, researchers\, patient advocates\, journalists and healthcare industry representatives from all over the world.\nESMO 2025 will be a place where groundbreaking discoveries\, cutting-edge treatments and a collaborative approach converge to shape the future of cancer care. \nYou will be able to learn from internationally renowned experts\, engage in thought-provoking discussions and connect with fellow oncology professionals that are driving advancements in diagnosis\, treatment and survivorship. \nA comprehensive educational and scientific programme will foster exchange and debate of translational cancer science\, showcase first announcements of potentially practice changing data and stimulate multidisciplinary discussions to improve treatment options for our patients. \nLearning objectives\n\nTo review and be updated on prevention\, screening and early diagnosis of cancer\nTo be updated on the latest breakthroughs in basic science\, translational and clinical cancer research\nTo analyze and understand the clinical perspective of the scientific advances in cancer biology\, diagnostics\, and new treatments\nTo learn the optimal roles of novel diagnostics and treatments for patients with cancer\n\nRegister NowMeet Our Partner\n\n\n\n\nMeet Mindpeak\, a pioneer in AI-powered pathology solutions helping labs accelerate cancer diagnostics with precision and efficiency. \nCatch them at ESMO 2025 — Booth #4010.  \nDiscover how AI is reshaping the future of oncology. \n\n\n\n\n\n\n\n\nAccreditation\nESMO-MORA: The Congress programme will be accredited with ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possess the necessary skills and standards for the practice of medical oncology. See here for further details . \nDisclaimer\nESMO is a scientific and professional\, non-political and non-religious organisation. ESMO will not accept responsibility for any comments or remarks made during any of our events by session chairs\, invited speakers\, presenters\, members or any other contributor\, formally or informally\, which might cause offence or be perceived as being biased. \nThe experts invited by ESMO as abstract Discussants are selected on an individual basis to provide their own interpretation of the data and are not acting as ESMO spokespersons. \nAll Speakers and Discussants are required to declare their interests\, if any\, and include a Declaration of Interest (DOI) slide at the start of their presentation(s). \nThe ESMO recommendations on the clinical utility of new drugs are only presented in the ESMO Clinical Practice Guidelines and such recommendations represent the only official position of ESMO.
URL:https://www.pathologynews.com/event/esmo-congress-2025/
LOCATION:Messe Berlin\, Messedamm 22\, Berlin\, 14055\, Germany
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/07/ESMO-Congress-2025.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251020
DTEND;VALUE=DATE:20251022
DTSTAMP:20260830T154859
CREATED:20250624T132630Z
LAST-MODIFIED:20250731T142434Z
UID:100113792-1760918400-1761091199@www.pathologynews.com
SUMMARY:Conference on Artificial Intelligence in Medical Imaging
DESCRIPTION:0000Days00Hrs00Min00Sec\n\n\nCMIMI is now SIIM-CAIMI!\n\n\n\n\n\n\nNew name. Sharper focus. Same cutting-edge research.\n\n\n\n\n\nUnparalleled Research Focus\n\n\n\n\n\n\nIn-depth talks from top AI and imaging research centers with live Q&A\nA space to test ideas\, challenge norms\, and refine AI approaches\nAccepted abstracts published in the Supplement to the Journal of Imaging Informatics in Medicine\n\n\n\n\n\n\n\n\nImmersive Scientific Discussions\n\n\n\n\n\n\nDeep dives into methods\, results\, and clinical relevance\nDiscussions on AI bias\, model generalizability\, and regulatory considerations\nCase study-driven conversations connecting theory to real-world impact\n\n\n\n\n\n\n\n\n\n\nA Multidisciplinary Community\n\n\n\n\n\n\nConnect with researchers\, clinicians\, and industry leaders in an intimate setting\nBuild partnerships across academia and industry\nBe part of a welcoming environment for trainees and early-career professionals\n\n\n\n\n\n\n\n\n\n\n\n\nAI in Action – From Research to Real-World Applications\n\n\n\n\n\n\nCutting-edge model development for accuracy and explainability\nReal-world AI integration in imaging workflows\nEthics and regulation for responsible AI deployment\n\n\n\n\n\n\n\n\nRegister Now
URL:https://www.pathologynews.com/event/conference-on-artificial-intelligence-in-medical-imaging/
LOCATION:University of California\, Irvine\, CA\, United States
CATEGORIES:In Person Event
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/06/Conference-on-Artificial-Intelligence-in-Medical-Imaging.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20251021T160000
DTEND;TZID=Europe/London:20251021T170000
DTSTAMP:20260830T154859
CREATED:20250827T154822Z
LAST-MODIFIED:20250827T154822Z
UID:100115293-1761062400-1761066000@www.pathologynews.com
SUMMARY:Multi-Omics Analysis Demonstrates Repetitive Head Impacts Induce Neuronal Loss and Neuroinflammation in Young Athletes
DESCRIPTION:0000Days00Hrs00Min00SecLearn how HALO image analysis is helping to advance the understanding of chronic traumatic encephalopathy!\nSummaryRepetitive head impacts (RHI) sustained from contact sports are the largest risk factor for chronic traumatic encephalopathy (CTE). Currently\, CTE can only be diagnosed after death and the multicellular cascade of events that trigger initial hyperphosphorylated tau (p-tau) deposition remain unclear. Further\, the symptoms endorsed by young individuals with early disease are not fully explained by the extent of p-tau deposition\, severely hampering development of therapeutic interventions. Using genomics\, spatial transcriptomics\, and histology it was observed that RHI exposure associates with a multicellular response in young individuals (<51 years old) prior to the onset of CTE p-tau pathology that correlates with number of years of RHI exposure. SPP1+ inflammatory microglia\, angiogenic and inflamed endothelial cell profiles\, reactive astrocytes\, and altered synaptic gene expression in excitatory and inhibitory neurons were identified in all individuals with exposure to RHI. Surprisingly\, elevation in collagen deposition around blood vessels that might be related to long term disease outcomes was also observed. Overall\, these results provide robust evidence that multiple years of RHI exposure is sufficient to induce lasting cellular alterations that may underlie p-tau deposition and help explain the early pathogenesis in young former contact sport athletes. \nLearning Objectives\nUnderstand how HALO image analysis can assist in characterizing pathology in neurodegenerative diseases \nUnderstand how HALO AI can be used to identify unique cell populations with complex\, varied shapes \nExplore how genomic data can be validated using histologic images analysis\n\nRegister NowPresenterJonathan Cherry\, PhD \nResearch Health Scientist \nVA Boston Healthcare System \nDirector\, Digital Pathology Core & Research Neuropathologist \nBoston University Alzheimer’s Disease Research Center and Boston University Chronic Traumatic Encephalopathy Center \nAssistant Professor of Pathology and Laboratory Medicine\nBoston University Avedisian & Chobanian School of Medicine \nDr. Cherry is an Assistant Professor of Pathology and Laboratory Medicine. He completed his undergraduate studies with a BS in biology at Ursinus College in 2008\, earned his doctoral degree in Pathology from the University of Rochester in 2015\, and joined the McKee laboratory as a postdoctoral researcher the same year. He was appointed as an assistant professor at Boston University School of Medicine in 2019. Dr. Cherry also holds a research health scientist position within the VA Boston Healthcare System. His laboratory space is located at the Jamaica Plain VA hospital where he performs his research and helps support the UNITE brain bank.  \nDr. Cherry’s research interests focus on understanding how neuroinflammation after repetitive traumatic brain injury contributes to CTE pathogenesis. Specifically\, Dr. Cherry seeks to identify what role microglia and inflammatory cytokines play in the early onset of hyperphosphorylated tau accumulation and spread.  \nDr. Cherry’s research also extends to histology analysis and machine learning. He is the director of the BU digital pathology core. This research entails exploring novel ways to analyze human postmortem tissue using machine learning algorithms for neuropathologic targets and better characterize pathology across a spectrum of neurodegenerative diseases including Alzheimer’s disease\, chronic traumatic encephalopathy\, frontotemporal lobar degeneration\, motor neuron diseases\, and others. 
URL:https://www.pathologynews.com/event/multi-omics-analysis-demonstrates-repetitive-head-impacts-induce-neuronal-loss-and-neuroinflammation-in-young-athletes/
LOCATION:Online
CATEGORIES:Live Online Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/08/Multi-Omics-Analysis-Demonstrates-Repetitive-Head-Impacts-Induce-Neuronal-Loss-and-Neuroinflammation-in-Young-Athletes.jpg
END:VEVENT
END:VCALENDAR